Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes
Abstract Dysregulation of glucagon secretion in type 1 diabetes (T1D) involves hypersecretion during postprandial states, but insufficient secretion during hypoglycemia. The sympathetic nervous system regulates glucagon secretion. To investigate islet sympathetic innervation in T1D, sympathetic tyro...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/06c0546e7343448f81538ebc42c845a0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:06c0546e7343448f81538ebc42c845a0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:06c0546e7343448f81538ebc42c845a02021-12-02T16:35:56ZIslet sympathetic innervation and islet neuropathology in patients with type 1 diabetes10.1038/s41598-021-85659-82045-2322https://doaj.org/article/06c0546e7343448f81538ebc42c845a02021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85659-8https://doaj.org/toc/2045-2322Abstract Dysregulation of glucagon secretion in type 1 diabetes (T1D) involves hypersecretion during postprandial states, but insufficient secretion during hypoglycemia. The sympathetic nervous system regulates glucagon secretion. To investigate islet sympathetic innervation in T1D, sympathetic tyrosine hydroxylase (TH) axons were analyzed in control non-diabetic organ donors, non-diabetic islet autoantibody-positive individuals (AAb), and age-matched persons with T1D. Islet TH axon numbers and density were significantly decreased in AAb compared to T1D with no significant differences observed in exocrine TH axon volume or lengths between groups. TH axons were in close approximation to islet α-cells in T1D individuals with long-standing diabetes. Islet RNA-sequencing and qRT-PCR analyses identified significant alterations in noradrenalin degradation, α-adrenergic signaling, cardiac β-adrenergic signaling, catecholamine biosynthesis, and additional neuropathology pathways. The close approximation of TH axons at islet α-cells supports a model for sympathetic efferent neurons directly regulating glucagon secretion. Sympathetic islet innervation and intrinsic adrenergic signaling pathways could be novel targets for improving glucagon secretion in T1D.Martha Campbell-ThompsonElizabeth A. ButterworthJ. Lucas BoatwrightMalavika A. NairLith H. NasifKamal NasifAndy Y. RevellAlberto RivaClayton E. MathewsIvan C. GerlingDesmond A. SchatzMark A. AtkinsonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-17 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Martha Campbell-Thompson Elizabeth A. Butterworth J. Lucas Boatwright Malavika A. Nair Lith H. Nasif Kamal Nasif Andy Y. Revell Alberto Riva Clayton E. Mathews Ivan C. Gerling Desmond A. Schatz Mark A. Atkinson Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes |
description |
Abstract Dysregulation of glucagon secretion in type 1 diabetes (T1D) involves hypersecretion during postprandial states, but insufficient secretion during hypoglycemia. The sympathetic nervous system regulates glucagon secretion. To investigate islet sympathetic innervation in T1D, sympathetic tyrosine hydroxylase (TH) axons were analyzed in control non-diabetic organ donors, non-diabetic islet autoantibody-positive individuals (AAb), and age-matched persons with T1D. Islet TH axon numbers and density were significantly decreased in AAb compared to T1D with no significant differences observed in exocrine TH axon volume or lengths between groups. TH axons were in close approximation to islet α-cells in T1D individuals with long-standing diabetes. Islet RNA-sequencing and qRT-PCR analyses identified significant alterations in noradrenalin degradation, α-adrenergic signaling, cardiac β-adrenergic signaling, catecholamine biosynthesis, and additional neuropathology pathways. The close approximation of TH axons at islet α-cells supports a model for sympathetic efferent neurons directly regulating glucagon secretion. Sympathetic islet innervation and intrinsic adrenergic signaling pathways could be novel targets for improving glucagon secretion in T1D. |
format |
article |
author |
Martha Campbell-Thompson Elizabeth A. Butterworth J. Lucas Boatwright Malavika A. Nair Lith H. Nasif Kamal Nasif Andy Y. Revell Alberto Riva Clayton E. Mathews Ivan C. Gerling Desmond A. Schatz Mark A. Atkinson |
author_facet |
Martha Campbell-Thompson Elizabeth A. Butterworth J. Lucas Boatwright Malavika A. Nair Lith H. Nasif Kamal Nasif Andy Y. Revell Alberto Riva Clayton E. Mathews Ivan C. Gerling Desmond A. Schatz Mark A. Atkinson |
author_sort |
Martha Campbell-Thompson |
title |
Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes |
title_short |
Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes |
title_full |
Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes |
title_fullStr |
Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes |
title_full_unstemmed |
Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes |
title_sort |
islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/06c0546e7343448f81538ebc42c845a0 |
work_keys_str_mv |
AT marthacampbellthompson isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes AT elizabethabutterworth isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes AT jlucasboatwright isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes AT malavikaanair isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes AT lithhnasif isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes AT kamalnasif isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes AT andyyrevell isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes AT albertoriva isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes AT claytonemathews isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes AT ivancgerling isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes AT desmondaschatz isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes AT markaatkinson isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes |
_version_ |
1718383673990971392 |